MissionIR Articles
-
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Q3 Earnings Call with Key Regulatory and Initiative Updates
HeartBeam (NASDAQ: BEAT), a medical technology company focused on enhancing cardiac care through advanced insights, will hold a conference call on November 7, 2024, at 4:30 p.m. ET to discuss third-quarter results and share updates…
-
MissionIRNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) CEO Details Promising Phase 3 Path for Alzheimer’s Treatment on The BioMedWire Podcast
Annovis Bio (NYSE: ANVS) led by Founder, President and CEO Dr. Maria Maccecchini, shares exciting developments regarding its pioneering Alzheimer’s and Parkinson’s drug candidate, buntanetap. In her interview on IBN’s BioMedWire Podcast, Dr. Maccecchini discusses…
-
MissionIRNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Moving Closer to Providing Much-Needed Treatments to Patients
Annovis Bio (NYSE: ANVS) is a late-stage clinical drug platform company pioneering novel therapies for neurodegenerative diseases. Recent clinical trials of the company’s lead compound yielded encouraging results, with buntanetap shown to improve cognition in…
-
Tiny Island in the Caribbean Gets Windfall as AI Boom Gathers Steam
While it is common knowledge that investors in tech firms like Nvidia Corp. (NASDAQ: NVDA) are accumulating fortunes from AI, the island of Anguilla is also minting serious cash from this industry. This started at…
-
McEwen Mining Inc. (NYSE: MUX) (TSX: MUX): Tapping into Argentina’s Growing Copper Potential
Argentina is rapidly emerging as a key player in the global mining industry, positioning itself to become a significant producer of copper and other minerals critical to the world’s clean energy transition. The country’s ambition…
-
Annovis Bio Inc. (NYSE: ANVS) Gets FDA Clearance for Buntanetap Pivotal Phase 3 Trials, Market Enthusiasm Highlighted in GuruFocus Article
Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), recently secured the approval of the U.S. Food and Drug…
-
D-Wave Quantum Inc. (NYSE: QBTS) Discusses Quantum Optimization, Presents Customer Success Stories at 2024 INFORMS Annual Meeting
D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, recently participated in the 2024 INFORMS Annual Meeting, highlighting its quantum optimization solutions and…
-
MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) Set to Discuss Lead Candidate Biomarker with FDA Leadership
Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and…
-
Domestic Violence Case Highlights Importance of SuperCom Ltd. (NASDAQ: SPCB) GPS-enabled Electronic Monitoring Technology
Behind the crime statistics related to domestic violence, and efforts to provide a supportive society to its victims, are personal stories of fear and loss, as exhibited by the son of a domestic violence victim…
-
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Wins 2024 Digital Health Hub Award for Innovation in Cardiac Care
HeartBeam (NASDAQ: BEAT), a medical technology company focused on advancing cardiac care, was recognized with the 2024 Digital Health Hub Rising Star award in the ‘Home Health Diagnostic’ category at the HLTH global healthcare conference.…
-
Annovis Bio Inc. (NYSE: ANVS) Receives FDA Clearance to Initiate Pivotal Phase 3 Alzheimer’s Studies, Paving the Way for NDA Filings
Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company focused on developing transformative therapies for neurodegenerative disorders, including Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), recently announced a significant milestone in its drug development…
-
Companies like McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) will Capitalize on the Growing Demand for AI Resources
Artificial intelligence is rapidly reshaping the landscape of economies around the world. Estimates indicate that generative AI alone will triple its growth to a total market value of $1.3 trillion in the next decade. As…
-
Groundbreaking Work on AI Wins Duo Nobel Prize in Physics
Geoffrey Hinton, undeniably referred to as “the Godfather of AI,” has been awarded the Nobel Prize in Physics alongside John Hopfield for their groundbreaking work that triggered the development of machine learning, the science behind…
-
Clene Inc. (NASDAQ: CLNN) Presents Lead Candidate CNM-Au8(R) Updates, Latest Achievements at Top Investor Conferences
Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) multiple…
-
EM Tech Developer SuperCom Ltd. (NASDAQ: SPCB) Secures New Monitoring Contract with the Israel Prison Service Agency
Electronic monitoring (“EM”) technology innovator SuperCom (NASDAQ: SPCB) recently secured a new contract with the Israel Prison Service state agency (“IPS”) to provide full-service EM capabilities for all electronically monitored criminal offender programs throughout the country. SuperCom…
-
D-Wave Quantum Inc. (NYSE: QBTS) Introduces Service-Level Agreements for Leap(TM) Quantum Cloud Service Customers Moving to Production
D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, has introduced service-level agreements (“SLAs”) tailored for customers of its Leap quantum cloud service…
-
Golden Opportunity: Why McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Shines Amid Surging Demand for Critical Minerals
Gold has been surging in popularity and value. Just this year, the precious metal has increased by approximately 28%, reaching a peak of more than $2,680 per ounce. In addition to Federal Reserve rate cuts…
Search Articles
Latest Articles
- A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) Advancing Retail Innovation Through AI-Powered Smart-Cart Technology
- Forward Industries Inc. (NASDAQ: FWDI) Positive Update for Shareholders After Debuting the Company’s Solana Treasury Strategy
- Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Secures Funding to Strengthen North American Supply Chain
- MissionIRNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Featured in BioMedWire Editorial on Rare Disease Therapies
- MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Talks Bold Strategy to Treat GBM in BioMedWire Podcast